Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.

INTRODUCTION: In resource-limited settings, the mortality rate among tuberculosis and human Immunodeficiency virus co-infected children is higher. However, there is no adequate evidence in Ethiopia in general and in the study area in particular. Hence, this study aims to estimate lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest Ethiopia Hospitals, 2021. METHODS: Institution-based historical follow-up study was conducted in Northwest Ethiopia Hospitals among 227 Tuberculosis and Human Immunodeficiency Virus co-infected children from March 1, 2014, to January 12, 2021. The data were entered into Epi info-7 and then exported to STATA version 14 for analysis. The log-rank test was used to estimate the curve difference of the predictor variables. Bivariable cox-proportional hazard models were employed for each predictor variable. Additionally, those variables having a p-value < 0.25 in bivariate analysis were fitted into a multivariable cox-proportional hazards model. P-value < 0.05 was used to declare significance associated with the dependent variable. RESULTS: From a total of 227 TB and HIV co-infected children, 39 died during the follow-up period. The overall mortality rate was 3.7 (95% CI (confidence interval): 2.9-4.7) per 100 person-years with a total of 1063.2-year observations. Cotrimoxazole preventive therapy (CPT) non-users [Adjusted Hazarded Ratio (AHR) = 3.8 (95% CI: 1.64-8.86)], presence of treatment failure [AHR = 3.0 (95% CI: 1.14-78.17)], and Cluster of differentiation 4(CD4) count below threshold [AHR = 2.7 (95% CI: 1.21-6.45)] were significant predictors of mortality. CONCLUSION: In this study, the mortality rate among TB and HIV co-infected children was found to be very high. The risk of mortality among TB and HIV co-infected children was associated with treatment failure, CD4 count below the threshold, and cotrimoxazole preventive therapy non-users. Further research should conduct to assess and improve the quality of ART service in Northwest Ethiopia Hospitals.

Determination of Aflatoxins in Edible Oils from China and Ethiopia Using Immunoaffinity Column and HPLC-MS/MS.

Background: Aflatoxin (AF) ingestion through contaminated foodstuffs causes at least 250000 deaths every year from hepatocellular carcinoma in China and sub-Saharan Africa. Objective: The main objective of the study was to determine the aflatoxin levels of oils in South Gondar, Ethiopia, and oils purchased from retail markets in Guangzhou, China. Methods: We used a rapid, sensitive, and selective HPLC-tandem mass spectrometry (MS/MS) method for the determination of aflatoxins in edible oils from China and Ethiopia using immunoaffinity column cleaning. Results: The level of contamination for Ethiopian oils ranged between 0.07 and 145.59 µg/kg for total aflatoxins. Of the 27 edible oil samples from Guangzhou, China, the total concentration of aflatoxins (AFB1 + AFB2 + AFG1 + AFG2) ranged between 0.03 and 2.23 µg/kg. Conclusions: The study concluded that the peanut oils from Ethiopia were contaminated with aflatoxins higher than the allowable limit set by many countries while the oils from China were safe for human consumption. Highlights: We first describe an HPLC-MS/MS method for the determination of aflatoxins in 48 edible oil samples from China and Ethiopia using immunoaffinity column cleaning. This is the first preliminary study done on Ethiopian edible oils, giving policy-makers and future researchers baseline data. It is also used to assess the aflatoxin levels of the Chinese edible oils from Guangzhou. Therefore, conducting a comparative study points out the severity of the problem and helps to formulate a new national standard for policy-makers, making this study imperative.